Add to ORKGOxaliplatin has been proved to be effective in themanagement of colorectal cancer. In combina-tion with folinic acid and fluorouracil, they can im-prove the survival rate of the patients with stage III and stage IV colorectal cancer. The dose-limiting side effect of oxaliplatin is neuropathy. It hampers the suc
Patients with colorectal carcinoma progressing after a 5-fluorouracil (5-FU)-containing regimen were...
Background Oxaliplatin (L-OHP) is a platinum complex that possesses activity against human and murin...
Objective: Oxaliplatin/ 5- Fluorouracil/ Leucovorin is an effective therapy for patients with metast...
BACKGROUND: The objective of the current prospective, multicenter, international study was to trace ...
Background: Infusional fluorouracil (5-FU) and leucovorin (LV) with oxaliplatin is one of the curren...
Objective: Previously, we suggested that oxaliplatin (L-OHP)-related grade 3/4 hypersensitivity reac...
Objective. Oxaliplatin-induced peripheral neurotoxicity continues to be a kind of frequent dose-limi...
Background: Prolonged neurotoxicity after systemic chemotherapy has the potential to impact on quali...
INTRODUCTION: Oxaliplatin, a third-generation platinum analogue, is a novel compound with proven ant...
Colon cancer commonly has distant metastasis to the liver, lung, lymph node, and bone; most pa-tient...
<p>A) The effect of oxaliplatin on the viability of human colorectal cancer cells. Caco-2, SW1116 an...
Introduction: Oxaliplatin‑induced neurotoxicity is the single main dose‑limiting factor in the treat...
International audienceBackground Adjuvant chemotherapy for colorectal cancer is mainly based on the ...
Oxaliplatin (Eloxatin; Sanofi-Synthelabo Inc.; New York, NY) is a third-generation platinum agent in...
Poster abstractS. Vatandoust, R. Joshi, K. Pittman, A. Esterman, V. Broadbridge, J. Adams, N. Singha...
Patients with colorectal carcinoma progressing after a 5-fluorouracil (5-FU)-containing regimen were...
Background Oxaliplatin (L-OHP) is a platinum complex that possesses activity against human and murin...
Objective: Oxaliplatin/ 5- Fluorouracil/ Leucovorin is an effective therapy for patients with metast...
BACKGROUND: The objective of the current prospective, multicenter, international study was to trace ...
Background: Infusional fluorouracil (5-FU) and leucovorin (LV) with oxaliplatin is one of the curren...
Objective: Previously, we suggested that oxaliplatin (L-OHP)-related grade 3/4 hypersensitivity reac...
Objective. Oxaliplatin-induced peripheral neurotoxicity continues to be a kind of frequent dose-limi...
Background: Prolonged neurotoxicity after systemic chemotherapy has the potential to impact on quali...
INTRODUCTION: Oxaliplatin, a third-generation platinum analogue, is a novel compound with proven ant...
Colon cancer commonly has distant metastasis to the liver, lung, lymph node, and bone; most pa-tient...
<p>A) The effect of oxaliplatin on the viability of human colorectal cancer cells. Caco-2, SW1116 an...
Introduction: Oxaliplatin‑induced neurotoxicity is the single main dose‑limiting factor in the treat...
International audienceBackground Adjuvant chemotherapy for colorectal cancer is mainly based on the ...
Oxaliplatin (Eloxatin; Sanofi-Synthelabo Inc.; New York, NY) is a third-generation platinum agent in...
Poster abstractS. Vatandoust, R. Joshi, K. Pittman, A. Esterman, V. Broadbridge, J. Adams, N. Singha...
Patients with colorectal carcinoma progressing after a 5-fluorouracil (5-FU)-containing regimen were...
Background Oxaliplatin (L-OHP) is a platinum complex that possesses activity against human and murin...
Objective: Oxaliplatin/ 5- Fluorouracil/ Leucovorin is an effective therapy for patients with metast...